LGND - Ligand Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LGND is currently covered by 2 analysts with an average price target of $199.3. This is a potential upside of $16.69 (9.14%) from yesterday's end of day stock price of $182.61.

Ligand Pharmaceuticals's activity chart (see below) currently has 130 price targets and 75 ratings on display. The stock rating distribution of LGND is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90.48% with an average time for these price targets to be met of 383.85 days.

Highest price target for LGND is $175, Lowest price target is $125, average price target is $149.4.

Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 02-Sep-2025. First documented stock forecast 11-Feb-2014.

Currently out of the existing stock ratings of LGND, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$175

$5.28 (3.11%)

$135

1 months 4 days ago
(02-Sep-2025)

9/10 (90%)

$11.27 (6.88%)

215

Buy

$143

$-26.72 (-15.74%)

$140

9 months 25 days ago
(11-Dec-2024)

5/5 (100%)

$22.64 (18.81%)

305

Buy

$147

$-22.72 (-13.39%)

$135

10 months 28 days ago
(08-Nov-2024)

2/2 (100%)

$25.75 (21.24%)

280

Buy

$125

$-55.99 (-30.94%)

$110

11 months 9 days ago
(27-Oct-2024)

13/13 (100%)

$11.62 (10.25%)

549

Buy

$157

$-23.99 (-13.25%)

$229

11 months 16 days ago
(20-Oct-2024)

25/29 (86.21%)

$50.22 (47.03%)

670

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LGND (Ligand Pharmaceuticals) average time for price targets to be met?

On average it took 383.85 days on average for the stock forecasts to be realized with a an average price target met ratio 90.48

Which analyst has the current highest performing score on LGND (Ligand Pharmaceuticals) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals)?

Scott Henry works at ALLIANCE GLOBAL PARTNERS and has 7 price targets and 4 ratings on LGND

Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals)?

Robert Wasserman with highest potential upside - $5.28

Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals)?

Esther Rajavelu with lowest potential downside - -$115.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?